SUNNYVALE, CALIF. July 28: Cepheid, a Danaher company, and a leader in molecular diagnostics, will unveil the third generation of the GeneXpert system at the Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting in a special booth presentation on Tuesday, July 28. The next-generation system is designed to expand the possibilities of PCR-based diagnostics while preserving the simplicity, flexibility, and reliability that have made the GeneXpert system the world’s most popular sample-to-answer PCR testing system.1
At product launch, the new GeneXpert system is designed to support Cepheid’s comprehensive menu of U.S. FDA-cleared tests, and the familiar workflows laboratories rely on today, while introducing a fully integrated touchscreen interface, redesigned software and a more intuitive user experience.
Looking ahead, the system is designed to support a new generation of Xpert® tests and applications, including high-plex panel testing, fast time-to-result, and sample-to-answer solutions that may extend to next-generation sequencing (NGS) workflows.
“Healthcare providers increasingly need access to different types of molecular testing, yet those capabilities are often spread across multiple instruments and workflows,” said Connie Savor, Chief Medical Officer at Cepheid. “The third-generation GeneXpert system is designed to bring a broader spectrum of molecular diagnostic capabilities onto a single system, helping clinicians access the insights they need to make informed decisions across the continuum of care. This launch serves as an example of how Cepheid and Danaher are helping solve some of the hardest problems in healthcare with global partners, including clinicians.”
“This is Cepheid’s next chapter,” said James Green, Chief Technology Officer at Cepheid. “We designed the third-generation GeneXpert system to support increasingly sophisticated molecular diagnostics while maintaining the simplicity, scalability, and ease of use that customers expect from GeneXpert systems. It’s how our teams continuously accelerate ideas to impact.”
Like all GeneXpert systems, the new system offers true random-access testing, allowing samples to be processed as they arrive rather than in batches. This gives laboratories the flexibility to prioritize urgent testing while maintaining rapid access to actionable results across a wide range of healthcare settings.
The first system to launch will be the compact four-module configuration, which is expected to begin shipping to U.S. customers in the coming months. Additional configurations, including higher-capacity GeneXpert systems and GeneXpert Infinity systems, are currently in development.
